Skip to content

Released Nov 8, 2022, after the close

10-Q filed Nov 9, 2022, 40 days after period end · 0001636422-22-000051

Q3 2022 · 10-Q
Revenue$68.35M+10.7% vs Q3 2021−3.2% vs Q2 2022
Net Income-$45.74MN/M vs Q3 2021N/M vs Q2 2022
EPS Diluted-$0.84N/M vs Q3 2021N/M vs Q2 2022
Operating Income-$45,721,000N/M
Operating Cash Flowderived-$12,031,000N/M
Free Cash Flowderived-$13,225,000N/M
Margins · derived
Operating margin-66.9%+1.5 pt vs Q3 2021
Net margin-66.9%−2.1 pt vs Q3 2021

What the release said

The release

Same quarter

MetricQ3 2022Q3 2021Q3 2020Q3 2019
Revenue$68.35M$61.74M$47.19M$39.42M
Net Income-$45.74M-$40.01M-$27.33M-$21.42M
EPS Diluted-$0.84-$0.82-$0.68-$1.40

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR